3-10435342-T-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001001331.4(ATP2B2):​c.199+14003A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.253 in 151,960 control chromosomes in the GnomAD database, including 6,902 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.25 ( 6902 hom., cov: 32)

Consequence

ATP2B2
NM_001001331.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.255

Publications

3 publications found
Variant links:
Genes affected
ATP2B2 (HGNC:815): (ATPase plasma membrane Ca2+ transporting 2) The protein encoded by this gene belongs to the family of P-type primary ion transport ATPases characterized by the formation of an aspartyl phosphate intermediate during the reaction cycle. These enzymes remove bivalent calcium ions from eukaryotic cells against very large concentration gradients and play a critical role in intracellular calcium homeostasis. The mammalian plasma membrane calcium ATPase isoforms are encoded by at least four separate genes and the diversity of these enzymes is further increased by alternative splicing of transcripts. The expression of different isoforms and splice variants is regulated in a developmental, tissue- and cell type-specific manner, suggesting that these pumps are functionally adapted to the physiological needs of particular cells and tissues. This gene encodes the plasma membrane calcium ATPase isoform 2. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]
ATP2B2 Gene-Disease associations (from GenCC):
  • hearing loss, autosomal dominant 82
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • autosomal recessive nonsyndromic hearing loss 12
    Inheritance: AD Classification: STRONG Submitted by: PanelApp Australia
  • neurodevelopmental disorder
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.492 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ATP2B2NM_001001331.4 linkc.199+14003A>G intron_variant Intron 2 of 22 ENST00000360273.7 NP_001001331.1 Q01814-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ATP2B2ENST00000360273.7 linkc.199+14003A>G intron_variant Intron 2 of 22 5 NM_001001331.4 ENSP00000353414.2 Q01814-1

Frequencies

GnomAD3 genomes
AF:
0.252
AC:
38332
AN:
151842
Hom.:
6887
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.498
Gnomad AMI
AF:
0.0837
Gnomad AMR
AF:
0.266
Gnomad ASJ
AF:
0.152
Gnomad EAS
AF:
0.359
Gnomad SAS
AF:
0.243
Gnomad FIN
AF:
0.104
Gnomad MID
AF:
0.222
Gnomad NFE
AF:
0.124
Gnomad OTH
AF:
0.226
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.253
AC:
38395
AN:
151960
Hom.:
6902
Cov.:
32
AF XY:
0.254
AC XY:
18886
AN XY:
74296
show subpopulations
African (AFR)
AF:
0.498
AC:
20602
AN:
41388
American (AMR)
AF:
0.267
AC:
4070
AN:
15264
Ashkenazi Jewish (ASJ)
AF:
0.152
AC:
527
AN:
3468
East Asian (EAS)
AF:
0.360
AC:
1855
AN:
5158
South Asian (SAS)
AF:
0.244
AC:
1172
AN:
4808
European-Finnish (FIN)
AF:
0.104
AC:
1106
AN:
10608
Middle Eastern (MID)
AF:
0.211
AC:
62
AN:
294
European-Non Finnish (NFE)
AF:
0.124
AC:
8453
AN:
67950
Other (OTH)
AF:
0.223
AC:
472
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
1282
2565
3847
5130
6412
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
366
732
1098
1464
1830
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.158
Hom.:
1566
Bravo
AF:
0.280
Asia WGS
AF:
0.269
AC:
933
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
1.5
DANN
Benign
0.67
PhyloP100
-0.26
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs929707; hg19: chr3-10477026; API